We have become accustomed to referring to the last couple of years as
‘unprecedented’. However, the life sciences, biomedical and healthcare
communities have regularly bound together in common purpose to tackle
the pressing issues of our times. Though the challenges we face are
rarely as novel as the SARS-CoV-2 outbreak, those issues do have global
impact on people’s lives and health. This is why, as the world emerges
from the worst of the pandemic, we are accelerating our work at Tecan to
make critical lab processes and medical procedures even more precise,
reproducible and accessible. We are continuing to work arm-in-arm with
our research and industry partners to find where collaboration accelerates
innovation, not just to drive success in the market, but to create farreaching,
scalable solutions that add value and improve people’s health.
